✕
Accure Therapeutics fait partie des excellentes entreprises qui font partie d'ELITE, l'écosystème paneuropéen du groupe Euronext qui aide les petites et moyennes entreprises à se développer et à accéder aux marchés de capitaux privés et publics.
Rejoindre le réseau ELITEDescription
Accure Therapeutics is a private translational neuroscience R&D company Based in Barcelona (it was launched in 2020 with a Series A funding led by Alta Life Sciences Spain I and supported by the Centre for Technological and Industrial Development). This European company with an international mindset boasts a unique portfolio of three new chemical entity programs pursuing innovative targets with potential to accommodate others. Accure aims to develop new disease modifying drugs to treat serious conditions such as optic neuritis, multiple sclerosis, ParkinsonParkinson’s disease and epilepsy. With an experienced business and scientific team, Accure Therapeutics is one of the few companies that operate in an agnostic fashion on initial science to deliver cutting edge drugs in CNS. To learn more visit https://accure.health/
Informations commerciales
PAYS
Spain
Membres
Actionnaires
Description de l'activité